Cargando…
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299272/ https://www.ncbi.nlm.nih.gov/pubmed/34322239 http://dx.doi.org/10.1002/ccr3.4300 |